OCS-01: A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery (clinicaltrials.gov) - Dec 7, 2021 - P3; N=240; Not yet recruiting; Sponsor: Oculis
Clinical • New P3 trial • Cataract • Immunology • Inflammation • Ocular Inflammation • Ophthalmology • Pain
|